Table of Contents
Volume 4 | Issue 3
Publication Date: December 2005- Abstract
- No Access
- Pay-Per View
- Full Text
- Add to Cart
Editorials | ||
154 |
Clinical Genitourinary Cancer: A Broadening of Scope Oliver Sartor |
|
155 |
Renal Cell Carcinoma: A New Era? Ronald M. Bukowski |
|
Meeting Highlights | ||
156-159 |
Highlights from: the International Conference on Molecular Targets and Cancer Therapeutics: Discovery, Biology, and Clinical Applications; Philadelphia, PA; November 2005; ECCO 13The European Cancer Conference; Paris, France; October 30 - November 3, 2005 Kesava Reddy, Amy DOrazio, Eric Nadler, Vinay K. Jain |
|
Comprehensive Reviews | ||
160-166 |
Perioperative Complications of Radical Retropubic Prostatectomy Joseph R. Sterbis, Stephen A. Brassell, David G. McLeod |
|
167-174 |
Sorafenib: Scientific Rationales for Single-Agent and Combination Therapy in Clear-Cell Renal Cell Carcinoma Jared A. Gollob |
|
175-180 |
SU11248 and AG013736: Current Data and Future Trials in Renal Cell Carcinoma Brian I. Rini |
|
181-186 |
Cytokine Therapy: A Standard of Care for Metastatic Renal Cell Carcinoma? Thomas E. Hutson, David I. Quinn |
|
187-192 |
Prostate Cancer Therapy with High-Intensity Focused Ultrasound Thomas A. Gardner, Michael O. Koch |
|
193-196 |
What Constitutes High-Risk Locally Advanced Prostate Cancer? Heather D. Mannuel, Arif Hussain |
|
Translational Medicine | ||
197-202 |
Antiangiogenesis: A Possible Treatment Option for Prostate Cancer? Ritchie L. Longoria, Michael C. Cox, William D. Figg |
|
203-211 |
Cyclooxygenase-2: A Therapeutic Target for Prostate Cancer Raj S. Pruthi, Eric M. Wallen |
|
Current Trials | ||
212-214 |
Radiation Therapy Oncology Group 0521: A Phase III Randomized Trial of Androgen Suppression and Radiation Therapy Versus Androgen Suppression and Radiation Therapy Followed by Chemotherapy with Docetaxel/Prednisone for Localized, High-Risk Prostate Cancer Asmita R. Patel, Howard M. Sandler, Kenneth J. Pienta |
|
215-218 |
A Phase I Study of a DNA Vaccine Targeting Prostatic Acid Phosphatase in Patients with Stage D0 Prostate Cancer Sarah Zlotocha, Mary Jane Staab, Dorothy Horvath, Jane Straus, Jeanne Dobratz, Katherine Oliver, Stephine Wasielewski, Dona Alberti, Glenn Liu, George Wilding, Jens Eickhoff, Douglas G. McNeel |
|
Clinical Trials | ||
219 |
Selected Clinical Trails in Prostate Cancer CIG Media Group |